Chirhostim Injection, Powder, Lyophilized, For Solution
Product Images NDC 67066-005

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Chirhostim (NDC 67066-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chirhoclin, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Box (005lb517)

Label Box (005lb517)
ChiRhoStim® is a human secretin injection that comes in a vial with a dosage of 16 mcg/vial. It contains L-cysteine hydrochloride, mannitol, sodium chloride, and a lyophilized powder. The product should be stored in a freezer and reconstituted with 8 mL of Sodium Chloride For Injection USP. After reconstitution, each mL of the solution contains 2 mog/mL of human secretin. It is imperative to use this solution immediately after reconstitution while protecting it from light. The product is for intravenous use only and must be discarded if not used entirely. The manufacturer for this product is ChiRhoClin, Inc located in Burtonsville, MD 20866-6129.*
FDA Label Image

Label Vial (005lv517)

Label Vial (005lv517)
This is a description of a product called "Human Secretin for Injection" made by ChiRhoClin, Inc. The vial contains 16mg of human secretin, 1.5mg of HDC-E7066-0D5701 hydrochloride, 20mg of mannitol, and 9mg of sodium chloride. The product is a lyophilized powder and should be stored in the freezer at -20°C. The package insert provides instructions on how to reconstitute the powder using sodium chloride injection USP. Once reconstituted, each ml contains 2mg/ml of human secretin for intravenous use only. The user must discard any unused portion after reconstitution and protect the product from light. The expiration date and lot number are provided.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
The graph shows the peak bicarbonate levels in mEq/L for chronic pancreatitis patients (sick and recovered) and healthy subjects. The x-axis represents the increasing levels of peak bicarbonate, while the y-axis shows the number of subjects. The bicarbonate levels are measured in 0.2 meg/kg for healthy subjects and 1 CU/kg for chronic pancreatitis patients.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.